Nxera Pharma Provides Update on Neurocrine’s Progress with its Partnered Muscarinic ...
Tokyo, Japan and Cambridge, UK, 14 January 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) is pleased to report on progress ...
Yahoo Finance6 天
Nxera Pharma Provides Update on Neurocrine’s Progress with its Partnered Muscarinic ...
Tokyo, Japan and Cambridge, UK, 14 January 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) is pleased to report on progress being made by Neurocrine Biosciences ...
Taiwan News1 个月
Nxera Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Tokyo, Japan and Cambridge, UK, 20 December 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – announces that Chris Cargill, ...
PharmiWeb1 个月
Nxera Pharma and Shionogi Launch QUVIVIQ™ in Japan for Adults with Insomnia
Tokyo, Japan and Cambridge, UK, 19 December 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – and Shionogi & Co., Ltd. (“Shionogi”) ...
Business Insider1 个月
Nxera Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Tokyo, Japan and Cambridge, UK, 20 December 2024 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – announces that ...